Our team is attending ESMO 2024 in Barcelona!
VARCT Dx’s CSO, Mette Ørskov Agerbæk and VAR2 Pharma’s COO Frederico Pimenta will be there and are looking forward to catching up on the most recent developments in oncology. Come meet us at our poster #218P on Sunday to hear more about our latest work on using our first-in-class antibodies against oncofetal CS for cancer therapeutics and diagnostics, and connect with us through the ESMO app.